NIH Grant to further Familial Dysautonomia (FD) Research ROCKVILLE, Maryland. (August 10, 2015) – American Gene Technologies International, Inc. (AGT) today announced its receipt of an NIH Grant of $230,000 to further its Familial Dysautonomia (FD) research in 2015. Get the details below: NIH Grant Details
Anyone who has experienced the death of a loved one from a terrible illness can appreciate the life mission of Mr. Jeff Galvin, CEO of American Gene Technologies (AGT). Armed with a bachelor’s degree in Economics from Harvard University, Jeff and AGT work to develop new technologies to find cures for many life-threatening diseases, including HIV and AIDS. Below, Jeff… [Read More]
Subscribe to our press release and published article updates to be notified when we release new content!
Subscribe to our newsletter to keep up to date with all the latest news about AGT!